Download 3rd Annual Vit-Buckle Society Meeting

March 19-21, 2015 | Fontainebleau MiaMi beach
3rd Annual Vit-Buckle Society Meeting
2015
accreditation and credit Designation
This activity has been planned and implemented in accordance with the accreditation
requirements and policies of the Accreditation Council for Continuing Medical Education
through the joint providership of William Beaumont Hospital, Medical Conference
Planners, Inc. and the Vit-Buckle Society. William Beaumont Hospital is accredited
by the ACCME to provide continuing medical education for physicians.
William Beaumont Hospital designates this live activity for a maximum of
11.25 AMA PRA Category 1 Credit(s).™ Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
AuDInA M.
BErroCAl, MD
THoMAS A.
AlBInI, MD
JoHn W.
kITCHEnS, MD
r.V. PAul
CHAn, MD
r. roSS
lAkHAnPAl, MD
DErEk y.
kunIMoTo, MD, JD
CHArlES W.
MAngo, MD
gEETA A.
lAlWAnI, MD
CHArlES C.
Wykoff, MD, PhD
AnDrEW A.
MoSHfEgHI, MD, MBA
...................................................................................................................
Organizing
COMMiTTEE
Bienvenido TO VBS ViCE 2015!
If you are a VBS veteran, we are delighted to welcome
you back. If you are new to the VBS, you are in for a
treat – a retinal meeting with a unique format: a forum
aimed at energetic, up and coming vitreoretinal
specialists and surgeons willing to discuss medical
practices and surgical techniques in an open and highly
interactive environment among colleagues.
The distinction between faculty and audience is gone.
Everyone is a participant. Everyone is a speaker. Be
prepared to offer up your ideas, insights and challenges
by interacting with presenters, moderators, industry . . .
everyone. you will never attend a meeting that better
fosters constant interaction and engagement.
This meeting is made possible by your experiences and
knowledge as well as the support of the companies
listed. Their continued support of this forum geared for
lively exchange and discussion is testament to their
dedication to our profession.
now, share your experiences, voice your concerns and
thoughts, and most importantly leave this meeting
feeling that you contributed and learned something.
gracias for coming back to Miami, we look forward to
our time together!
THE VBS VICE ORGANIZING COMMITTEE
V B S V I C E 2 015
3
California retina Consultants
Santa Barbara, CA
caroline r. baumal, MD
Tufts Medical Center
Boston, MA
chris bergstrom, MD, oD
Emory Eye Center
Atlanta, gA
Maria h. berrocal, MD
university of Puerto rico
San Juan, Pr
harit K. bhatt, MD
Illinois Eye and Ear Infirmary
Chicago, Il
David M. brown, MD
retina Consultants of Houston
Houston, TX
antonio capone, Jr., MD
Associated retinal Consultants/
William Beaumont Hospital
royal oak, MI
Steve charles, MD
Charles retina Institute
Memphis, Tn
David r. chow, MD
university of Toronto
Toronto, on, Canada
Donald J. D’amico, MD
Weill Cornell Medical College/
new york-Presbyterian
new york, ny
4
V B S V I C E 2 015
David a. eichenbaum, MD
retina-Vitreous Associates of florida
St. Petersburg, fl
andres emanuelli, MD
Arecibo, Pr
christiane i. Falkner-radler, MD
ludwig Boltzmann Institute of retinology
and Biomicroscopic laser Surgery
rudolf foundation Clinic
Vienna, Austria
harry W. Flynn, Jr., MD
Bascom Palmer Eye Institute
Miami, fl
Matteo Forlini, MD
university of Modena
Modena, Italy
Jans Fromow-Guerra, MD, PhD
Hospital Dr. luis Sanchez Bulnes
Asociación Para Evitar
la Ceguera en México
Mexico City, Mexico
Gerardo Garcia-aguirre, MD
Hospital Dr. luis Sanchez Bulnes
Asociación Para Evitar
la Ceguera en México
Mexico City, Mexico
Victor h. Gonzalez, MD
Valley retina Institute
McAllen, TX
evangelos S. Gragoudas, MD
Massachusetts Eye and Ear Infirmary
Boston, MA
ninel Z. Gregori, MD
Bascom Palmer Eye Institute
Miami, fl
....................................................................................................................
robert l. avery, MD
....................................................................................................................
....................................................................................................................
Faculty
Paul hahn, MD, PhD
Duke Eye Center
Durham, nC
lawrence S. halperin, MD
retina group of florida
Boca raton, fl
J. William harbour, MD
Bascom Palmer Eye Institute
Miami, fl
tarek S. hassan, MD
Associated retinal Consultants/
William Beaumont Hospital
royal oak, MI
Dianna l. hoskins
Cincinnati Eye Institute
Cincinnati, oH
G. baker hubbard, MD
Emory Eye Center
Atlanta, gA
bernard r. hurley, MD
university of ottawa Eye Institute
ottawa, Canada
Jonathan Jonish, MD
long Island Vitreoretinal Consultants
great neck, ny
rahul n. Khurana, MD
uC San francisco, CA · northern California
retina Vitreous Associates
San Mateo, CA
ivana K. Kim, MD
Massachusetts Eye and Ear Infirmary
Boston, MA
John W. Kitchens, MD
retina Associates of kentucky
lexington, ky
linda a. lam, MD
uSC keck School of Medicine
los Angeles, CA
Yannek i. leiderman, MD
university of Illinois,
College of Medicine at Chicago
Chicago, Il
theodore leng, MD
Stanford School of Medicine
Palo Alto, CA
Phoebe lin, MD, PhD
Casey Eye Institute
oregon Health and Science university
Portland, or
tamer h. Mahmoud, MD, PhD
Duke university Eye Center
Durham, nC
James c. Major, Jr., MD, PhD
retina Consultants of Houston
Houston, TX
efrem D. Mandelcorn, MD
Toronto Western Hospital
university of Toronto
Toronto, on, Canada
tara a. Mccannel, MD, PhD
Jules Stein Eye Institute/uClA
los Angeles, CA
Virgilio Morales-canton, MD
Hospital Dr. luis Sanchez Bulnes
Asociación Para Evitar
la Ceguera en México
Mexico City, Mexico
andrew a. Moshfeghi, MD, Mba
uSC keck School of Medicine
los Angeles, CA
Prithvi Mruthyunjaya, MD
Duke Eye Center
Durham, nC
timothy G. Murray, MD, Mba
Murray ocular oncology and retina
Miami, fl
carmen rosina negrin, MD
Medicalnet
Santo Domingo, Dr
lisa c. olmos de Koo, MD, Mba
uSC keck School of Medicine
los Angeles, CA
Kirk h. Packo, MD
rush university Medical Center
Chicago, Il
Samir Patel, MD
ophthotech Corporation
new york, ny
carmen a. Puliafito, MD, Mba
uSC keck School of Medicine
los Angeles, CA
hugo Quiroz-Mercado, MD
Denver Health Medical Center
university of Colorado School of Medicine
Denver, Co
aleksandra V. rachitskaya, MD
Cole Eye Institute · Cleveland Clinic
Cleveland, oH
carl D. regillo MD
Mid Atlantic retina/Wills Eye Institute
Philadelphia, PA
....................................................................................................................
retinal Consultants of Arizona
Phoenix, AZ
....................................................................................................................
....................................................................................................................
Derek Y. Kunimoto, MD, JD
Philip J. rosenfeld, MD, PhD
Bascom Palmer Eye Institute
Miami, fl
andrew M. Schimel, MD
florida International university
Wertheim College of Medicine
Miami, fl
Gaurav K. Shah, MD
retina Institute St. louis
St. louis, Mo
robert a. Sisk, MD
Cincinnati Eye Institute
Cincinnati, oH
lucia Sobrin, MD, MPh
Massachusetts Eye and Ear Infirmary
Boston, MA
Sunil K. Srivastava, MD
Cole Eye Institute · Cleveland Clinic
Cleveland, oH
charles c. Wykoff, MD, PhD
retina Consultants of Houston
Houston, TX
Deepa Yoganathan, MD
university of Toronto
Toronto, on, Canada
David n. Zacks, MD, PhD
kellogg Eye Center
university of Michigan
Ann Arbor, MI
V B S V I C E 2 015
5
...................................................................................................................
6
V B S V I C E 2 015
VBS Keynote SpeAKer
FriDaY, March 20 • 2:30 PM
From Concept to reality:
What i’ve Learned
along the Way
CarMEn a. PuLiaFiTO, MD, MBa
Carmen A. Puliafito, MD, MBA is the dean of the keck School of Medicine of uSC and
holder of the May S. and John Hooval Dean’s Chair in Medicine. Prior to leading the
keck School, he was director of the Bascom Palmer Eye Institute and chair of the
Department of ophthalmology of the university of Miami Miller School of Medicine.
Previously, he was founding director of the new England Eye Center and chair of the
Department of ophthalmology at Tufts university.
Throughout his career Dr. Puliafito has been an innovator, most recently participating
in the introduction of bevacizumab (Avastin) for the treatment of retinal disorders. He
was the first to describe the use of the semiconductor diode laser for retinal photocoagulation, and he did pioneering basic science research in excimer laser photoablation and optical breakdown and photodisruption. He established a major optical
imaging program while at the university of Miami, and is still actively working with his
laboratory team investigating novel retinal imaging approaches at uSC, most notably
an initial description of the novel technique of photo acoustic ophthalmoscopy.
Dr. Puliafito is recognized as co-inventor of the technology of optical coherence
tomography (oCT) and with being the first ophthalmologist to use this technology to
study the human macula in health and disease. from the first publication about oCT
in 1991 to the implementation of the first clinical system two years later, Dr. Puliafito
has led in the development of oCT technology – a technology which has truly revolutionized retinal practice and made a real difference for both patients and retinal
specialists. from a single system at the new England Eye Center at Tufts university
School of Medicine in 1993, oCT has grown to have a global impact, now with more
than 20,000 systems in use every day throughout the world. for his work on oCT,
Dr. Puliafito was awarded (along with James fujimoto and Eric Swanson) the 2002
rank Prize – the world’s most prestigious award in optoelectronics. In 2012, also for
his work on oCT, Dr. Puliafito was awarded (along with James fujimoto, Eric Swanson,
David Huang and Joel Schuman) the Champalimaud Vision Award, often called the
“nobel Prize for Vision.”
Keynote Speaker Honorees
A graduate of Harvard College and Harvard Medical
2013 Stanley Chang, MD
School, Dr. Puliafito earned his MBA from the Wharton
School of Business of the university of Pennsylvania.
2014 William S. Tasman, MD
..................................................................................................................
VBS LIFetIMe
MentorSHIp AWArD
SaturDaY, March 21 • 12:00 PM
Proton Beam irradiation
of uveal Melanomas:
The First Forty Years
EVangELOS gragOuDaS, MD
Dr. Evangelos gragoudas has been the Director of retina Service at the Massachusetts
Eye and Ear Infirmary since 1985 and has trained more that 100 clinical fellows and
over 50 research fellows from all over the world. He is a leading clinician-researcher
and has spent over 25 years investigating treatments for intraocular tumors and
macular disorders. He is considered a world authority on the diagnosis and management of ocular tumors and is world-renowned for his groundbreaking work in the use
of proton irradiation to treat intraocular melanoma. Dr. gragoudas has long-standing interest in photodynamic therapy (PDT) for the
treatment of ocular tumors and ocular neovascularization. He collaborated with Dr.
Joan W. Miller on preclinical studies of PDT using the light-sensitive dye, Verteporfin,
for the treatment of choroidal neovascularization. Dr. gragoudas was instrumental in
designing and executing the early clinical studies and was an integral member of the
study group and writing group for the large clinical trials. Based on these large clinical
trials, photodynamic therapy using Verteporfin was approved by the health authorities
throughout the world and became the first widely used treatment for neovascular
retinal disease that effectively slowed disease progression.
Dr. gragoudas also pioneered work on ocular angiogenesis and anti-angiogenesis therapy.
He worked with a group of ophthalmologists, including Drs. Joan Miller, Tony Adamis,
Pat D’Amore and others in collaboration with the laboratory of noted angiogenesis
discoverer, Dr. Judah folkman. This team first demonstrated the critical role of vascular
endothelial growth factor (VEgf) in ocular neovascularization and went on to develop
therapies targeting VEgf. Macugen®, the first compound based on this approach
effectively slowed the progression of age-related macular degeneration (AMD), the
most frequent cause of blindness in patients over age 60. A second-generation pharmaceutical, lucentis® was found to result in vision improvement for the first time in
approximately one-third of patients with neovascular AMD who underwent treatment.
Dr. gragoudas completed his medical training in Athens,
greece and his ophthalmology residency at Boston
university School of Medicine. Dr. gragoudas has published over 200 articles in peer-reviewed journals and
Lifetime Mentorship
award Honorees
2013 Allan E. kreiger, MD
written or authored more than 100 chapters, reviews,
and books; he lectures nationally and internationally.
2014 Harry W. flynn, Jr., MD
V B S V I C E 2 015
7
6:00 PM-9:00 PM
FeLLoWS’ ForAy
(a non-CME event)
fleur De lis Ballroom
SEE SEPARATE PROGRAM
Friday, March 20
8:00 aM-6:00 PM
registration
fleur De lis Ballroom foyer
8:00-9:00 aM
Breakfast
fontaine Ballroom
8:00 aM-6:00 PM
Exhibits
fontaine Ballroom
8:55 aM-6:00 PM
Scientific Sessions
fleur De lis Ballroom
8:55-9:00 aM
Opening remarks
Charles C. Wykoff, MD, PhD
9:00-11:00 aM
SCIENTIFIC SESSION 1:
Surgery outside of
the Box 120
Moderators: g. Baker Hubbard, MD, David
M. Brown, MD, Donald J. D’Amico, MD 9:00 aM
Pneumoves
Efrem D. Mandelcorn, MD V B S V I C E 2 015
....................................................................................................................
....................................................................................................................
8
Thursday, March 19
9:15 aM
intraoperative OCT Christiane I. falkner-radler, MD
9:25 aM
intraoperative OCT Sunil k. Srivastava, MD 9:35 aM
Trauma and intraocular
Foreign Bodies Aleksandra V. rachitskaya, MD
9:45 aM
Lessons from the “retinal
Detachment Following ruptured
globe” Trenches Deepa yoganathan, MD
9:55 aM
27 gauge:
gimmick or game Changer
Theodore leng, MD 10:10 aM
Chandelier Buckles: initial Experience
Tamer H. Mahmoud, MD, PhD 10:20 aM
“Pole to Pole” Surgery Matteo forlini, MD 10:30 aM
Chorioretinal Biopsies
and Endoresections
Phoebe lin, MD, PhD 10:45 aM
Creating the Bionic Eye:
Surgical Pearls for implanting
a retinal Prosthesis
lisa C. olmos de koo, MD, MBA
ninel Z. gregori, MD
Break
11:30 aM-1:15 PM
SCIENTIFIC SESSION 2:
Medical retina Debates
Moderators: robert l. Avery, MD, Carl D.
regillo, MD, Philip J. rosenfeld, MD, PhD,
Charles C. Wykoff, MD, PhD 11:30 aM
The 2015 revised guidelines for
intravitreal injection
Harry W. flynn, Jr., MD
SAFety ISSUeS
11:45 aM
using T/E to improve Safety Carl D. regillo, MD 11:55 aM
Systemic Safety Concerns
with anti-VEgF agents robert l. Avery, MD
12:15 PM
Macular atrophy after
anti-VEgF Therapy
Moderators: Andrew A. Moshfeghi, MD, MBA
and Philip J. rosenfeld, MD, PhD
DMe: IntereStInG AnD
CoMpLeX CASe MAnAGeMent
12:35 PM
Panelists: Antonio Capone, Jr., MD, David A.
Eichenbaum, MD, Victor H. gonzalez, MD,
Andrew A. Moshfeghi, MD, MBA, Charles C.
Wykoff, MD, PhD
....................................................................................................................
....................................................................................................................
11:00-11:30 aM
GenetICS
1:00 PM The Current role of genetic Testing
in retina Practice
lucia Sobrin, MD, MPH
1:15-2:30 PM
Lunch 1:30-2:20 PM
industry Presentations
(a non-CME event)
Moderator: geeta A. lalwani, MD
Alcon laboratories, Inc.
Allergan, Inc.
Bausch + lomb
Dutch ophthalmic uSA
genentech, Inc.
Insight Instruments, Inc.
oCuluS Surgical Inc.
Quantel Medical
regeneron Pharmaceuticals, Inc.
Synergetics, Inc.
2:30-3:15 PM
Keynote LeCtUre
From Concept to reality:
What i’ve Learned along the Way
one on one Interview:
Carmen A. Puliafito, MD, MBA,
interviewed by John W. kitchens, MD
3:15-4:00 PM
SCIENTIFIC SESSION 3:
Bench to Bedside
Moderator: Derek y. kunimoto, MD, JD
Panelists: Steve Charles, MD, Samir
Patel, MD, Carmen A. Puliafito, MD, MBA,
David n. Zacks, MD, PhD 4:00-4:30 PM
Break
V B S V I C E 2 015
9
SCIENTIFIC SESSION 4:
Surgical Complications
Moderators: David r. Chow, MD,
Tarek S. Hassan, MD, kirk H. Packo, MD,
Andrew M. Schimel, MD 4:30 PM
get Back in There! an unusual
Postoperative Complication
Jonathan Jonisch, MD 4:45 PM
Headache after Macular Hole repair
Harit k. Bhatt, MD
5:00-6:00 PM
Surgical Complications
Panel Discussion Moderator: Andrew M. Schimel, MD
Panelists: David r. Chow, MD, Tarek S.
Hassan, MD, kirk H. Packo, MD
6:00 PM
adjourn
8:00-11:00 PM
Dinner at Liv
Saturday, March 21
8:00 aM-4:05 PM
registration
fleur De lis Ballroom foyer
8:00-9:00 aM
Breakfast
fontaine Ballroom
8:00 aM-2:45 PM
Exhibits
fontaine Ballroom
V B S V I C E 2 015
....................................................................................................................
....................................................................................................................
10
4:30-6:00 PM
9:00 aM-4:05 PM
Scientific Sessions
fleur De lis Ballroom
9:00-11:00 aM
SCIENTIFIC SESSION 5:
rD Management
Moderators: Antonio Capone, Jr., MD,
yannek I. leiderman, MD, PhD,
Carl D. regillo, MD 9:00 aM
The right Way to Do a Pr Caroline r. Baumal, MD 9:12 aM
Valved Cannulae –
Keepin’ it Quiet
Paul Hahn, MD, PhD
9:24 aM
Tactics for Efficient repair of
Diabetic TrD – The Vitrectomy Probe
as Swiss army Knife
yannek I. leiderman, MD
9:36 aM
Check Out This Baby! James C. Major, Jr., MD, PhD
9:48 aM
Diabetic Vitrectomy: How to
Survive if You’re not Maria Berrocal
robert A. Sisk, MD 10:00 aM
The art of and the Practical
approach to PVr Management –
How to get 90% anatomic Success
with Patient and referral Smiles
kirk H. Packo, MD
Scleral Fixation with
gore-Tex and an akreos iOL rahul n. khurana, MD 10:30-11:00 aM
rApID FIre SeCtIon Moderators: Caroline r. Baumal, MD,
linda A. lam, MD, yannek I. leiderman, MD
10:30 aM
relaxing retinectomy
in Posterior Break
Paul Hahn, MD, PhD
10:35 aM
rD Management Decisions
gaurav k. Shah, MD 11:00-11:30 aM
Break
11:30 aM-12:00 PM
SCIENTIFIC SESSION 6:
ocular oncology for
every retina Specialist:
Case Discussions
Moderators: Prithvi Mruthyunjaya, MD
and Timothy g. Murray, MD, MBA
Panelists: Chris Bergstrom, MD, oD,
Evangelos S. gragoudas, MD,
J. William Harbour, MD, Ivana k. kim, MD,
Tara A. McCannel, MD, PhD 12:00 PM
VBS LIFetIMe MentorSHIp
AWArD LeCtUre
Proton Beam irradiation of uveal
Melanomas: The First Forty Years
Introduction: r.V. Paul Chan, MD
recipient: Evangelos S. gragoudas, MD ....................................................................................................................
....................................................................................................................
10:20 aM
12:45-2:45 PM
Lunch/Wetlab
2:45-3:15 PM
SCIENTIFIC SESSION 7:
Coding: Aggressive
vs. Conservative
Moderators: lawrence S. Halperin, MD
and John W. kitchens, MD
Panelist: Dianna l. Hoskins (Director
Patient Accounts, Cincinnati Eye Institute)
2:45-3:15
Coding Discussion
John W. kitchens, MD,
lawrence S. Halperin, MD,
and Dianna l. Hoskins
3:15-4:00 PM
SCIENTIFIC SESSION 8:
pan-American:
Broaden your Horizons
Moderators: Maria H. Berrocal, MD,
Virgilio Morales-Canton, MD,
Bernard r. Hurley, MD
Panelists: Andres Emanuelli, MD,
Jans fromow-guerra, MD, PhD,
gerardo garcia-Aguirre, MD,
Carmen rosina negrin, MD,
Hugo Quiroz-Mercado, MD 4:00-4:05 PM
Closing remarks
Thomas A. Albini, MD
7 :00 PM-MiDniGht
Dinner and awards Ceremony
fleur de lis and fontaine Ballrooms
Entertainment provided by
Bad Habits
“The EyeDocs of rock!”
V B S V I C E 2 015
11
THIS CME ACTIVITY IS SUPPORTED BY
EDUCATIONAL GRANTS FROM:
Alcon Laboratories, Inc.
Regeneron Pharmaceuticals, Inc.
Exhibitors
the Vit-buckle Society gratefully acknowledges
generous contributions from the following companies:
SaPPHirE
genentech, Inc.
PLaTinuM
Allergan, Inc.
regeneron Pharmaceuticals, Inc.
Synergetics, Inc.
gOLD
Alcon laboratories, Inc.
Insight Instruments, Inc.
Bausch + lomb
oCuluS Surgical, Inc.
Dutch ophthalmic uSA
Quantel Medical
SiLVEr
Alimera Sciences
Santen, Inc.
Carl Zeiss Meditec, Inc.
Thrombogenics, Inc.
Medone Surgical, Inc.
Topcon Medical Systems
notal Vision
VisionCare ophthalmic
Technologies, Inc.
retina Today
MEDiCaL COnFErEnCE PLannErS, inC.
914-722-0664
[email protected]
www.medconfs.com